These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 34821965)

  • 41. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
    Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
    Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Possibilities of bacteriophage therapy].
    Skurnik M; Kiljunen S
    Duodecim; 2016; 132(8):712-9. PubMed ID: 27244930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Susceptibilities of multidrug-resistant pathogens responsible for complicated skin and soft tissue infections to standard bacteriophage cocktails].
    Gündoğdu A; Kılıç H; Ulu Kılıç A; Kutateladze M
    Mikrobiyol Bul; 2016 Apr; 50(2):215-23. PubMed ID: 27175494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Basic Guidelines for Bacteriophage Isolation and Characterization.
    Samir S
    Recent Pat Biotechnol; 2023; 17(4):312-331. PubMed ID: 36263478
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toward a Phage Cocktail for Tuberculosis: Susceptibility and Tuberculocidal Action of Mycobacteriophages against Diverse Mycobacterium tuberculosis Strains.
    Guerrero-Bustamante CA; Dedrick RM; Garlena RA; Russell DA; Hatfull GF
    mBio; 2021 May; 12(3):. PubMed ID: 34016711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future.
    Łobocka M; Dąbrowska K; Górski A
    BioDrugs; 2021 May; 35(3):255-280. PubMed ID: 33881767
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bacteriophages as therapeutic & disinfectant agents to tackle multidrug-resistant
    Rathor N; Bahadur T; Thakur CK; Bamola VD; Das BK; Chaudhry R
    Indian J Med Res; 2023 Jun; 157(6):549-558. PubMed ID: 37530310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bactericidal Synergism between Phage YC#06 and Antibiotics: a Combination Strategy to Target Multidrug-Resistant Acinetobacter baumannii
    Luo J; Xie L; Liu M; Li Q; Wang P; Luo C
    Microbiol Spectr; 2022 Aug; 10(4):e0009622. PubMed ID: 35736241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nano-emulsion encapsulation for the efficient delivery of bacteriophage therapeutics.
    Samananda Singh L
    Biologicals; 2024 Feb; 85():101725. PubMed ID: 37951140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An exegesis of bacteriophage therapy: An emerging player in the fight against anti-microbial resistance.
    Adesanya O; Oduselu T; Akin-Ajani O; Adewumi OM; Ademowo OG
    AIMS Microbiol; 2020; 6(3):204-230. PubMed ID: 33134741
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phage Therapy for Antibiotic-Resistant Bacterial Infections.
    Hatfull GF; Dedrick RM; Schooley RT
    Annu Rev Med; 2022 Jan; 73():197-211. PubMed ID: 34428079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A simple solid media assay for detection of synergy between bacteriophages and antibiotics.
    Khong E; Oh JJ; Jimenez JM; Liu R; Dunham S; Monsibais A; Rhoads A; Ghatbale P; Garcia A; Cobián Güemes AG; Blanc AN; Chiu M; Kuo P; Proost M; Kline A; Aslam S; Schooley RT; Whiteson K; Fraley SI; Pride DT
    Microbiol Spectr; 2024 May; 12(5):e0322123. PubMed ID: 38526142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phage steering of antibiotic-resistance evolution in the bacterial pathogen,
    Gurney J; Pradier L; Griffin JS; Gougat-Barbera C; Chan BK; Turner PE; Kaltz O; Hochberg ME
    Evol Med Public Health; 2020; 2020(1):148-157. PubMed ID: 34254028
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bacteriophage therapy: an overview and the position of Italian Society of Infectious and Tropical Diseases.
    Cesta N; Di Luca M; Corbellino M; Tavio M; Galli M; Andreoni M
    Infez Med; 2020 Sep; 28(3):322-331. PubMed ID: 32920567
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections
    Kebriaei R; Lev KL; Shah RM; Stamper KC; Holger DJ; Morrisette T; Kunz Coyne AJ; Lehman SM; Rybak MJ
    Microbiol Spectr; 2022 Apr; 10(2):e0041122. PubMed ID: 35348366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phage for treatment of Vibrio cholerae infection.
    Mittal M; Tripathi S; Saini A; Mani I
    Prog Mol Biol Transl Sci; 2023; 201():21-39. PubMed ID: 37770173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bacteriophage therapy in children: facts and prospects.
    Fortuna W; Miedzybrodzki R; Weber-Dabrowska B; Górski A
    Med Sci Monit; 2008 Aug; 14(8):RA126-32. PubMed ID: 18668009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The current status of phage therapy and its advancement towards establishing standard antimicrobials for combating multi drug-resistant bacterial pathogens.
    Ali Y; Inusa I; Sanghvi G; Mandaliya VB; Bishoyi AK
    Microb Pathog; 2023 Aug; 181():106199. PubMed ID: 37336428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibiotics Act with vB_AbaP_AGC01 Phage against
    Grygorcewicz B; Roszak M; Golec P; Śleboda-Taront D; Łubowska N; Górska M; Jursa-Kulesza J; Rakoczy R; Wojciuk B; Dołęgowska B
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.